Skip to content

Clinical trials

Recruiting Phase 1/2 Mesothelioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Phase 1/2 Status: Recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20211
20221
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
A2 Biotherapeutics Inc.1
Baylor College of Medicine1
Beijing Biotech1
Genmab1
ModeX Therapeutics, An OPKO Health Company1
Orion Corporation, Orion Pharma1
Perspective Therapeutics1
Tango Therapeutics, Inc.1
VM Oncology, LLC1
Vivace Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma10
Carcinoma, Non-Small-Cell Lung5
Ovarian Neoplasms4
Pancreatic Neoplasms4
Esophageal Neoplasms3
Head and Neck Neoplasms3
Breast Neoplasms2
Cholangiocarcinoma2
Colonic Neoplasms2
Colorectal Neoplasms2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.